𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of integrin antagonist signaling by ligand binding of the heparin-binding domain of vitronectin to the αVβ3 integrin

✍ Scribed by Laura A. Maile; Ariel W. Aday; Walker H. Busby; Ravi Sanghani; Umadevi Veluvolu; David R. Clemmons


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
219 KB
Volume
105
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The interaction between the arginine glycine and aspartic acid motif (RGD) of integrin ligands such as vitronectin and the integrin receptor αVβ3 in mediating cell attachment has been well described. Similarly, the ability of disintegrins, small RGD containing peptides, to inhibit cell attachment and other cellular processes has also been studied extensively. Recently, we characterized a second site of interaction between vitronectin and its integrin partner. We determined that amino acids within the heparin‐binding domain of vitronectin bind to a cysteine loop (C‐loop) region of β3 and that this interaction is required for the positive effects of αVβ3 ligand occupancy on IGF‐I signaling in smooth muscle cells. In this study we examine the signaling events activated following ligand binding of disintegrins to the αVβ3 and the ability of these signals to be regulated by binding of the heparin‐binding domain of vitronectin. We demonstrate that disintegrin ligand binding activates a series of events including the sequential activation of the tyrosine kinases c‐Src and Syk. This leads to the activation of calpain and the cleavage of the β3 cytoplasmic tail. Addition of vitronectin or a peptide homologous to the heparin‐binding domain inhibited activation of this pathway. Our results suggest that the signaling events that occur following ligand binding to the αVβ3 integrin reflects a balance between the effects mediated through the RGD binding site interaction and the effects mediated by the heparin binding site interaction and that for intact vitronectin the effect of the heparin‐binding domain predominates. J. Cell. Biochem. 105: 437–446, 2008. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Role of the αI domain in ligand binding
✍ Elaine M. Corps; Alexis Robertson; M. Joy Dauncey; Peter J. Kilshaw 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

## Abstract The I domain of integrin αE was modeled on the crystal structure of that in CD11b and mutated to produce an open (high affinity) or closed (low affinity) conformation. K562 transfectants expressing mutant αE and wild‐type β7 were tested for adhesion to E‐cadherin‐Fc. Downward displaceme

Modulation of Ligand binding by alternat
✍ Thomas A. Bunch; Timmy L. Kendall; Kishore Shakalya; Daruka Mahadevan; Danny L. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

## Abstract The Drosophila αPS2 integrin subunit is found in two isoforms. αPS2C contains 25 residues not found in αPS2m8, encoded by the alternative eighth exon. Previously, it was shown that cells expressing αPS2C spread more effectively than αPS2m8 cells on fragments of the ECM protein Tiggrin,

Microglial expression of αvβ3 and αvβ5 i
✍ Richard Milner 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 368 KB

## Abstract As the primary immune effector cells in the CNS, microglia play a central role in regulating inflammation. The extracellular matrix (ECM) protein vitronectin is a strong inducer of microglial activation, switching microglia from a resting into an activated potentially destructive phenot